Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects
暂无分享,去创建一个
Y. Makino | M. Haneda | T. Kieffer | Y. Fujita | J. Honjo | A. Abiko | Y. Takiyama | Y. Takeda | T. Yanagimachi | Hiroya Kitsunai | H. Sakagami | Tsuyoshi Yanagimachi | Yasutaka Takeda | Hidemitsu Sakagami | Jun Honjo